Neuron in Need: UMN Startup Develops Tech for Neurological Diseases
A new company based on U of M technology stands to help advance studies into chronic neurological diseases like ALS, Parkinson’s and Alzheimer’s.
Anatomi Corp., a start-up company launched by University’s Technology Commercialization’s Venture Center in May, has developed technology to speed up the production of neurons made from stem cells. Producing these neurons allows researchers to faster test the effects of different treatments more efficiently.
Walsh launched Anatomi Corp. alongside co-founder and Chief Operations Officer Vincent Truong. The two were completing graduate degrees at the Carlson School of Management, but have since put their studies on hold to pursue Anatomi Corp.
“I just love advising these startups and watching them grow. It’s super fulfilling,” said Mary MacCarthy, venture program manager with the Venture Center. “One of the keys to advising these startups is how motivated they are and how coachable they are. Patrick and Vince are both super motivated and equally coachable.”
Read the full story in the Minnesota Daily.